Diagnosis of Ehlers-Danlos Syndrome
Ehlers-Danlos syndrome (EDS) is primarily diagnosed by specialists with expertise in connective tissue disorders, including geneticists, rheumatologists, or specialized multidisciplinary teams, with gastroenterologists increasingly playing a role in identifying and referring patients with hypermobile EDS. 1
Initial Assessment and Screening
Gastroenterologists often serve as initial screeners for hypermobile EDS (hEDS) when patients present with disorders of gut-brain interaction (DGBI) and should:
The Beighton scale evaluates:
- Passive extension of little fingers beyond 90 degrees
- Passive apposition of thumbs to forearm
- Hyperextension of elbows beyond 10 degrees
- Hyperextension of knees beyond 10 degrees
- Forward flexion of trunk with knees extended (palms to floor) 2
Diagnostic Pathway
For Hypermobile EDS (most common type):
- Clinical assessment using the 2017 diagnostic criteria checklist
- Exclusion of other conditions presenting with joint hypermobility
- Referral to genetics specialists for definitive diagnosis 3
For Vascular EDS (most serious type):
- Targeted genetic testing for the COL3A1 gene
- Non-invasive vascular imaging to assess for arterial abnormalities
- Avoidance of invasive diagnostic procedures due to tissue fragility 2
Specialist Involvement
Different specialists may be involved in EDS diagnosis depending on the subtype and presenting symptoms:
- Geneticists: Provide definitive diagnosis and genetic counseling, especially for types with known genetic mutations 4
- Rheumatologists: Evaluate joint hypermobility and musculoskeletal symptoms
- Cardiologists/Vascular specialists: Assess vascular manifestations, particularly in vascular EDS 2
- Gastroenterologists: Screen for hEDS in patients with DGBI and evaluate for associated conditions like POTS and MCAS 1
Associated Conditions Requiring Specialized Assessment
Postural Orthostatic Tachycardia Syndrome (POTS):
- Testing through postural vital signs (symptomatic increase in heart rate ≥30 beats/min with 10 minutes of standing)
- Referral to cardiology or neurology when indicated 1
Mast Cell Activation Syndrome (MCAS):
- Testing should be targeted to patients with clinical manifestations involving 2+ physiological systems
- Serum tryptase levels collected at baseline and 1-4 hours following symptom flares
- Increases of 20% above baseline plus 2 ng/mL indicate mast cell activation 1
Common Pitfalls in Diagnosis
- Failure to recognize EDS due to overlapping symptoms with other conditions
- Overreliance on genetic testing (especially for hEDS which has no known genetic marker)
- Inadequate assessment of vascular complications in suspected vascular EDS
- Failure to refer to appropriate specialists for definitive diagnosis 5, 6
Key Considerations
- EDS diagnosis remains challenging due to overlapping symptoms between subtypes
- The Villefranche classification and associated criteria are recommended for diagnosis 5
- Accurate diagnosis is crucial for appropriate management, prevention of complications, and genetic counseling 7
- Multidisciplinary assessment is often necessary for comprehensive evaluation and management 2
Remember that early recognition and appropriate referral by primary care physicians and specialists can help prevent devastating complications, particularly in vascular EDS where arterial and organ rupture can be life-threatening 7.